Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer's disease

Neuroscience Bulletin

Volumn 26, Issue 1, 2010, Pages 77-84

  Wei, Li Li ^a   Shen, Yue Di ^b   Zhang, Ying Chun ^a   Hu, Xing Yue ^a   Lu, Pei Ling ^a   Wang, Li ^a   Chen, Wei ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Inflammation; Prostaglandin E2; Prostaglandin E2 receptors

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 RECEPTOR EP1; PROSTAGLANDIN E2 RECEPTOR EP2; PROSTAGLANDIN E2 RECEPTOR EP3; PROSTAGLANDIN E2 RECEPTOR EP4; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; OCCLUSIVE CEREBROVASCULAR DISEASE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR BLOCKING; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; METABOLISM; REVIEW;

ALZHEIMER DISEASE; ANIMALS; DINOPROSTONE; HUMANS; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION;

EID: 76649098525     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-010-0703-z     Document Type: Short Survey

References (46)

1. Y. Wan G. Wang S.D. Chen 2008 Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease Neurosci Bull 24 314 322 10.1007/s12264-008-0619-z 1:CAS:528:DC%2BD1MXhtVyrsLrO 18839025
2. H. Akiyama S. Barger S. Barnum B. Bradt J. Bauer G.M. Cole, et al. 2000 Inflammation and Alzheimer's disease Neurobiol Aging 21 383 421 10.1016/S0197-4580(00)00124-X 1:CAS:528:DC%2BD3cXktVSmt74%3D 10858586 (Pubitemid 30349107)
3. M. Etminan S. Gill A. Samii 2003 Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies BMJ 327 128 10.1136/bmj.327.7407.128 1:CAS:528:DC%2BD3sXmsl2nu7o%3D 12869452
4. B.A. in t' Veld A. Ruitenberg A. Hofman L.J. Launer C.M. van Duijn T. Stijnen, et al. 2001 Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease N Engl J Med 345 1515 1521 10.1056/NEJMoa010178 (Pubitemid 33144916)
5. C.A. Szekely J.E. Thorne P.P. Zandi M. Ek E. Messias J.C. Breitner, et al. 2004 Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review Neuroepidemiology 23 159 169 10.1159/000078501 15279021 (Pubitemid 38980441)
6. P.T. Jantzen K.E. Connor G. DiCarlo G.L. Wenk J.L. Wallace A.M. Rojiani, et al. 2002 Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice J Neurosci 22 2246 2254 1:CAS:528:DC%2BD38XisVGisbo%3D 11896164
7. G.P. Lim F. Yang T. Chu P. Chen W. Beech B. Teter, et al. 2000 Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease J Neurosci 20 5709 5714 1:CAS:528:DC%2BD3cXlt1Gltbk%3D 10908610
8. Q. Yan J. Zhang H. Liu S. Babu-Khan R. Vassar A.L. Biere, et al. 2003 Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease J Neurosci 23 7504 7509 1:CAS:528:DC%2BD3sXmvFaisLg%3D 12930788
9. C.A. Szekely R.C. Green J.C. Breitner T. Ostbye A.S. Beiser M.M. Corrada, et al. 2008 No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies Neurology 70 2291 2298 10.1212/01.wnl.0000313933.17796.f6 1:CAS:528:DC%2BD1cXmsFylsrg%3D 18509093
10. Z. Arvanitakis F. Grodstein J.L. Bienias J.A. Schneider R.S. Wilson J.F. Kelly, et al. 2008 Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology Neurology 70 2219 2225 10.1212/01.wnl.0000313813. 48505.86 1:STN:280:DC%2BD1czmtVOjtQ%3D%3D 18519870
11. B. Zhang G.H. Du 2005 Anti-inflammatory mechanism of non-steroidal anti-inflammatory drugs Chin Pharm Bull 21 905 910 1:CAS:528: DC%2BD28XpvFKqtLk%3D
12. S. Weggen J.L. Eriksen S.A. Sagi C.U. Pietrzik T.E. Golde E.H. Koo 2003 Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain J Biol Chem 278 30748 30754 10.1074/jbc.M304824200 1:CAS:528:DC%2BD3sXmtFeqsLk%3D 12777371 (Pubitemid 36994581)
13. T. Hoshino T. Nakaya T. Homan K. Tanaka Y. Sugimoto W. Araki, et al. 2007 Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo J Biol Chem 282 32676 32688 10.1074/jbc.M703087200 1:CAS:528:DC%2BD2sXht1CltbnI 17767011 (Pubitemid 350159313)
14. X. Liang Q. Wang T. Hand L. Wu R.M. Breyer T.J. Montine, et al. 2005 Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease J Neurosci 25 10180 10187 10.1523/JNEUROSCI.3591-05.2005 1:CAS:528:DC%2BD2MXht1Wqt77I 16267225 (Pubitemid 41636214)
15. T. Takadera Y. Shiraishi T. Ohyashiki 2004 Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons Neurochem Int 45 713 719 10.1016/j.neuint.2004.02. 005 1:CAS:528:DC%2BD2cXlsVart7g%3D 15234114 (Pubitemid 38844893)
16. V. Echeverria A. Clerman S. Dore 2005 Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure Eur J Neurosci 22 2199 2206 10.1111/j.1460-9568. 2005.04427.x 16262658 (Pubitemid 41653533)
17. H. Slawik B. Volk B. Fiebich M. Hull 2004 Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum Neurochem Int 45 653 660 10.1016/j.neuint.2004.04.007 1:CAS:528:DC%2BD2cXmtlChtrY%3D 15234107 (Pubitemid 38844886)
18. F.S. Shie K.S. Montine R.M. Breyer T.J. Montine 2005 Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons Brain Pathol 15 134 138 1:CAS:528: DC%2BD2MXktlOht74%3D 15912885
19. L. McCullough L. Wu N. Haughey X. Liang T. Hand Q. Wang, et al. 2004 Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia J Neurosci 24 257 268 10.1523/JNEUROSCI.4485-03.2004 1:CAS:528: DC%2BD2cXotF2ltQ%3D%3D 14715958 (Pubitemid 38181690)
20. D. Liu L. Wu R. Breyer M.P. Mattson K. Andreasson 2005 Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia Ann Neurol 57 758 761 10.1002/ana.20461 1:CAS:528:DC%2BD2MXkvFykt7c%3D 15852374 (Pubitemid 40628868)
21. R.M. Breyer C.K. Bagdassarian S.A. Myers M.D. Breyer 2001 Prostanoid receptors: subtypes and signaling Annu Rev Pharmacol Toxicol 41 661 690 10.1146/annurev.pharmtox.41.1.661 1:CAS:528:DC%2BD3MXjsVaqt7g%3D 11264472 (Pubitemid 32385902)
22. R.J. Wilson S.A. Rhodes R.L. Wood V.J. Shield L.S. Noel D.W. Gray, et al. 2004 Functional pharmacology of human prostanoid EP2 and EP4 receptors Eur J Pharmacol 501 49 58 10.1016/j.ejphar.2004.08.025 1:CAS:528:DC%2BD2cXotFCltrY%3D 15464062 (Pubitemid 39298936)
23. H. Fujino S. Salvi J.W. Regan 2005 Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 Mol Pharmacol 68 251 259 1:CAS:528:DC%2BD2MXlvVSqu7s%3D 15855407
24. Y. Sugimoto S. Narumiya 2007 Prostaglandin E receptors J Biol Chem 282 11613 11617 10.1074/jbc.R600038200 1:CAS:528:DC%2BD2sXktFemtbs%3D 17329241 (Pubitemid 47100657)
25. F.S. Shie R.M. Breyer T.J. Montine 2005 Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity Am J Pathol 166 1163 1172 1:CAS:528:DC%2BD2MXjsFaksLc%3D 15793296
26. A.S. Ahmad S. Saleem M. Ahmad S. Dore 2006 Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage Toxicol Sci 89 265 270 10.1093/toxsci/kfj022 1:CAS:528:DC%2BD2MXhtlagtLfM 16237196 (Pubitemid 43013774)
27. T. Takadera T. Ohyashiki 2006 Prostaglandin E2 deteriorates N-methyl-D-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons Life Sci 78 1878 1883 10.1016/j.lfs.2005.08.026 1:CAS:528:DC%2BD28Xhsl2hsbs%3D 16309709 (Pubitemid 43295588)
28. A.M. Pooler A.A. Arjona R.K. Lee R.J. Wurtman 2004 Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia Neurosci Lett 362 127 130 10.1016/j.neulet.2004.03.013 1:CAS:528:DC%2BD2cXktlCqsb8%3D 15193769 (Pubitemid 38759083)
29. L. Wu Q. Wang X. Liang K. Andreasson 2007 Divergent effects of prostaglandin receptor signaling on neuronal survival Neurosci Lett 421 253 258 10.1016/j.neulet.2007.05.055 1:CAS:528:DC%2BD2sXmvVOgs7Y%3D 17574754 (Pubitemid 46935366)
30. E.O. Lee Y.J. Shin Y.H. Chong 2004 Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and betacatenin/T-cell factor J Neuroimmunol 155 21 31 10.1016/j.jneuroim.2004.05.012 1:CAS:528:DC%2BD2cXntlSnsro%3D 15342193 (Pubitemid 39165774)
31. M.G. Kazanietz M.J. Caloca P. Eroles T. Fujii M.L. Garcia-Bermejo M. Reilly, et al. 2000 Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties Biochem Pharmacol 60 1417 1424 10.1016/S0006-2952(00)00470-6 1:CAS:528: DC%2BD3cXntVWgsrs%3D 11020443 (Pubitemid 30742605)
32. L. Hui D.S. Pei Q.G. Zhang Q.H. Guan G.Y. Zhang 2005 The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation Brain Res 1052 1 9 10.1016/j.brainres.2005.05.043 1:CAS:528:DC%2BD2MXnslyisbo%3D 16018989 (Pubitemid 41116281)
33. H. Amano I. Hayashi H. Endo H. Kitasato S. Yamashina T. Maruyama, et al. 2003 Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth J Exp Med 197 221 232 10.1084/jem.20021408 1:CAS:528:DC%2BD3sXmt1Sjuw%3D%3D 12538661 (Pubitemid 36152316)
34. K. Kabashima T. Saji T. Murata M. Nagamachi T. Matsuoka E. Segi, et al. 2002 The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut J Clin Invest 109 883 893 1:CAS:528: DC%2BD38Xis1Kju70%3D 11927615
35. T.J. Montine D. Milatovic R.C. Gupta T. Valyi-Nagy J.D. Morrow R.M. Breyer 2002 Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent J Neurochem 83 463 470 10.1046/j.1471-4159.2002.01157.x 1:CAS:528:DC%2BD38XotFylur0%3D 12423256 (Pubitemid 35191411)
36. F.S. Shie K.S. Montine R.M. Breyer T.J. Montine 2005 Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity Glia 52 70 77 10.1002/glia.20220 15920732 (Pubitemid 41532139)
37. J. Jin F.S. Shie J. Liu Y. Wang J. Davis A.M. Schantz, et al. 2007 Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alphasynuclein J Neuroinflammation 4 2 10.1186/1742-2094-4-2 17204153 (Pubitemid 46189718)
38. C. Chen J.C. Magee N.G. Bazan 2002 Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity J Neurophysiol 87 2851 2857 1:CAS:528:DC%2BD38XltFSksrs%3D 12037188
39. T. Yagami H. Nakazato K. Ueda K. Asakura T. Kuroda S. Hata, et al. 2003 Prostaglandin E2 rescues cortical neurons from amyloid beta protein-induced apoptosis Brain Res 959 328 335 10.1016/S0006-8993(02)03773-3 1:CAS:528:DC%2BD38XpsFWjs7w%3D 12493622 (Pubitemid 35472195)
40. Y. Takahashi I. Hayashi Y. Tominari K. Rikimaru Y. Morohashi T. Kan, et al. 2003 Sulindac sulfide is a noncompetitive gammasecretase inhibitor that preferentially reduces Abeta 42 generation J Biol Chem 278 18664 18670 10.1074/jbc.M301619200 1:CAS:528:DC%2BD3sXjs1KhtLY%3D 12637581 (Pubitemid 36799494)
41. S. Weggen J.L. Eriksen S.A. Sagi C.U. Pietrzik V. Ozols A. Fauq, et al. 2003 Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gammasecretase activity J Biol Chem 278 31831 31837 10.1074/jbc.M303592200 1:CAS:528:DC%2BD3sXmsVOntbY%3D 12805356 (Pubitemid 37048365)
42. J. Li X. Liang Q. Wang R.M. Breyer L. McCullough K. Andreasson 2008 Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia Neurosci Lett 438 210 215 10.1016/j.neulet.2008.04.054 1:CAS:528:DC%2BD1cXmtlWhsrs%3D 18472336
43. T. Kawano J. Anrather P. Zhou L. Park G. Wang K.A. Frys, et al. 2006 Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity Nat Med 12 225 229 10.1038/nm1362 1:CAS:528:DC%2BD28XhtFajsro%3D 16432513 (Pubitemid 43214750)
44. M. Bilak L. Wu Q. Wang N. Haughey K. Conant C. St Hillaire, et al. 2004 PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis Ann Neurol 56 240 248 10.1002/ana.20179 1:CAS:528:DC%2BD2cXnt1enurg%3D 15293276 (Pubitemid 39037919)
45. A. Brunet S.R. Datta M.E. Greenberg 2001 Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway Curr Opin Neurobiol 11 297 305 10.1016/S0959-4388(00)00211-7 1:CAS:528: DC%2BD3MXks1Oktbw%3D 11399427 (Pubitemid 32524094)
46. W. Chen Y.D. Shen H.P. Yao G.S. Zhao 2005 Inhibition of lipopolysaccharide-induced expression of cyclooxygenase-2 in PC-12 cells by triptolide Chin Pharm J 40 274 277 1:CAS:528:DC%2BD28XhvF2jtbY%3D